HEXO
Aphria Q3 2019 Earnings Review – Headlines Create Opportunity
Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.
Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want
Organigram (CVE: OGI) posted another strong quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.
Canadian Cannabis Scorecard (Spring 2019)
Confused about which marijuana stocks are worth your money? The Canadian Cannabis Scorecard is your guide to separating the best…
HEXO Completes First Harvest At 1,000,000 Sq. Ft. Greenhouse
First announced back in October of 2018, HEXO Corp’s (TSX:HEXO; NYSE-A:HEXO) 1,000,000 sq. ft. greenhouse expansion is now operational and has completed…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (March 16th, 2019)
Edibles are Coming to Canada, but Will Regulations Doom the Market Bottom Line: We are starting to get worried that government…
HEXO Q2 2019 Earnings – On the Edge of Profitability
A full review of HEXO (TSE: HEXO) Q2 2019 earnings. Should you buy this value priced name or are there…
HEXO Corp Enters Agreement to Acquire Newstrike Brands
After recently wrapping up a greenhouse expansion project to increase production capacity, HEXO Corp (TSX: HEXO; NYSE-A: HEXO) is now further branching out…
Canopy Growth Q2 2019 Earnings Review – Big Growth With a Big Cost Structure to Match
Bottom Line: Investors will probably like this earnings release from Canopy Growth (TSE: WEED; NYSE: CGC). Net revenue of $83…
Aurora Cannabis Q2 2019 Earnings Review – Recreational Ramp Slower Than Expected
Bottom Line Aurora has arrived as a major player in the recreational market capturing ~20% market share of rec volumes…